10,756
Total Claims
$1.4M
Drug Cost
811
Beneficiaries
$1,717
Cost/Patient
Peer Comparison vs. 218,535 Nurse Practitioner providers
-95%
Opioid rate vs peers
0.2% vs 3.8% avg
+46%
Cost per patient vs peers
$1,717 vs $1,174 avg
+58%
Brand preference vs peers
14.0% vs 8.9% avg
Opioid Prescribing
0.2%
Opioid Rate
20
Opioid Claims
$199
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
86% generic
Brand: 1,490 claims · $1.2M
Generic: 9,137 claims · $171K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 64 | $127K |
| Apremilast | 23 | $107K |
| Apixaban | 82 | $101K |
| Evolocumab | 81 | $77K |
| Empagliflozin | 46 | $69K |
| Dulaglutide | 33 | $64K |
| Fluticasone/Umeclidin/Vilanter | 58 | $61K |
| Semaglutide | 32 | $60K |
| Insulin Glargine,hum.Rec.Anlog | 29 | $33K |
| Budesonide/Glycopyr/Formoterol | 36 | $33K |
| Insulin Degludec | 23 | $32K |
| Mirabegron | 37 | $31K |
| Tirzepatide | 14 | $30K |
| Dapagliflozin Propanediol | 16 | $26K |
| Denosumab | 15 | $25K |
Prescribing Profile
Patient Profile
74
Avg Age
61%
Female
1.67
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data